SARASOTA, Fla., July 28, 2016 (SEND2PRESS NEWSWIRE) — The Sarasota Florida attorney commented after a Philadelphia jury returned a verdict of $70 million against Johnson & Johnson for failing to warn of the risks associated for taking Risperdal. The case involved a sixteen-year-old boy who developed breast from the medication prescribed for attention deficit disorder (ADHD). The jury learned that Johnson & Johnson knew the risks associated with the drug, but did not disclose them.

Attorney David Shapiro
The verdict was on the heels of a payment of $2.2 billion fine to end a criminal investigation for promoting the drug for treatment for dementia and ADHD which the drug had not received approval for.

David Shapiro, a board certified civil trial lawyer commented, “You would think that large corporations would stop putting profits over the health of the consumers. But it seems that exorbitant fines and large verdicts doesn’t modify their behavior.”

Shapiro noted that Johnson & Johnson faces large verdicts for failing to warn customers of the risk for deadly ovarian cancer after use of talc products. “These products are ruining or taking people’s lives. The money won’t replace loved one’s or restore the victims, but I hope companies start to act responsibly and consider the devastation they bring on their consumers,” Shapiro said.

About Sarasota Attorney M. David Shapiro:
Attorney M. David Shapiro is an AV-rated civil trial lawyer, the highest rating awarded to litigation attorneys. He is also board certified by the Florida Bar. Shapiro is an experienced trial lawyer who has earned the respect of his peers in the legal community.

David has successfully litigated civil rights cases involving access to courts and rights under the Rehabilitation Act to the United States Supreme Court. For more than 20 years, Shapiro has practiced exclusively in the area of personal injury and wrongful death in Sarasota Florida

Shapiro Goldman Babboni & Walsh
308 Cocoanut Ave, Sarasota FL, 34236
Local: 941-954-4000

More about M. David Shapiro at:

News Source: Shapiro Delgado